Expand BOUT Menu
BOUT MENU

BOUT Stock Summary and Trading Ideas (Capforce Ibd Breakout Opportunities ETF | ARCA:BOUT)

Capforce Ibd Breakout Opportunities ETF (BOUT) Frequently Asked Questions

What does Capforce Ibd Breakout Opportunities ETF do?

The Fund will normally invest at least 80% of its net assets in the equity securities that comprise the IBD Breakout Stocks Index. The Fund generally invests in all of the securities comprising the Index in proportion to the weightings of the securities in the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index's initial universe consists of the approximately 7,000 equity securities that trade on the New York Stock Exchange, The Nasdaq Stock Market, LLC or NYSE American, LLC. This initial universe is composed of U.S.-listed common stocks and American depositary receipts ("ADRs") issued by small, mid and large capitalization companies. Each security chosen for inclusion in the Index and is assigned a ranking score using IBD's Composite Ranking, based upon the following components Earnings Per Share Rating, Relative Price Strength Rating, Industry Group Relative Strength Rating, Sales Margins Return on Equity ("SMR") Rating, Accumulation Distribution Rating and Percentage Deviation from 52-week Price High. The Index utilizes this ranking score to assign weights, with those stocks with higher rankings receiving larger weights.

What symbol and exchange does Capforce Ibd Breakout Opportunities ETF shares trade?

Capforce Ibd Breakout Opportunities ETF trades on the ARCA stock market under the symbol BOUT.

What is Capforce Ibd Breakout Opportunities ETF stock price doing today?

As of June 1, 2026, BOUT stock price climbed to $46.64 with 820 million shares trading.

How much is Capforce Ibd Breakout Opportunities ETF worth?

BOUT has a market cap of $16.32 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Capforce Ibd Breakout Opportunities ETF traded in the last 3 year period?

In the last 3 years, BOUT traded as high as $47.21 and as low as $28.66.

Is Capforce Ibd Breakout Opportunities ETF (BOUT) a good investment?

BOUT has outperformed the market in the last year with a return of +33.9%, while the SPY ETF gained +29.8%. In the last 3 month period, BOUT beat the market returning +14.2%, while SPY returned +10.8%. However, in the most recent 2 weeks BOUT has underperformed the stock market by returning +1.6%, while SPY returned +2.6%.

What are the support and resistance levels for Capforce Ibd Breakout Opportunities ETF (BOUT)?

BOUT support price is $45.89 and resistance is $47.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BOUT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes